Drug Shortage Report for NAROPIN
| Report ID | 127239 |
| Drug Identification Number | 02229411 |
| Brand name | NAROPIN |
| Common or Proper name | Naropin® (ropivacaine HCl 2mg/mL 5x200mL SU Polybag®) |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | EPIDURAL BLOCK/INFILTRATION BLOCK/INFILTRATION EPIDURAL |
| Packaging size | 5 PP Polybag |
| ATC code | N01BB |
| ATC description | ANESTHETICS, LOCAL |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2020-12-01 |
| Actual start date | 2020-12-02 |
| Estimated end date | 2022-02-11 |
| Actual end date | 2022-02-08 |
| Shortage status | Resolved |
| Updated date | 2022-02-10 |
| Company comments | VR89891CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.